Target(TGT)

Search documents
Target Corporation Increases Quarterly Dividend by 1.8 Percent
Prnewswire· 2024-06-12 10:30
MINNEAPOLIS, June 12, 2024 /PRNewswire/ -- The board of directors of Target Corporation (NYSE: TGT) has declared a quarterly dividend of $1.12 per common share, a 1.8% increase from the prior quarterly dividend of $1.10. The dividend is payable Sept. 10, 2024 to shareholders of record at the close of business August 21, 2024. The 3rd quarter dividend will be the company's 228th consecutive dividend paid since October 1967 when the company became publicly held. With the increase announced today, 2024 is o ...
Target, Dick's Sporting Goods facing pushback from investors for 'going woke'
Fox Business· 2024-06-12 10:11
Major retailers Target and Dick's Sporting Goods will both face criticism over "woke" policies at their respective shareholder meetings on Wednesday, as activist investors ramp up pressure on companies amid raging culture wars in the U.S. The National Center for Public Policy Research (NCPPR), a conservative think tank, plans to present proposals for a vote at each company, aimed at preventing the boards from making hyper-political decisions in the future, arguing that they have taken controversial position ...
Stallion Uranium Highlights Prospectivity of Intersected Conductive Structure at Appaloosa Target
GlobeNewswire News Room· 2024-06-12 10:00
VANCOUVER, British Columbia, June 12, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the significant advancements and interpretations from the maiden drill program completed on the Appaloosa target, located on its 100% owned Coffer Project. Appaloosa is an advanced exploration target that is part of its broader portfolio of high-potential uranium projects held by Stallion in the prolific southwestern Athabasca Basin, ...
Target Hospitality Provides Update on South Texas Family Residential Center Located in Dilley Texas
Prnewswire· 2024-06-11 02:25
THE WOODLANDS, Texas, June 10, 2024 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically integrated modular accommodations and value-added hospitality services, today received notice that the U.S. government intends to terminate the existing South Texas Family Residential Center ("STFRC") services agreement with Target's migrant programming partner ("STFRC Partner"), effective in 60 days, or on or abou ...
Nvidia's First Trading Day After Its Stock Split Brings Slight Gain and Price-Target Hikes
Investopedia· 2024-06-10 22:20
Key TakeawaysNvidia shares finished slightly higher Monday after the chipmaker's 10-for-1 stock split, and several analysts raised their price targets for the stock. Barclays, Susquehanna, and TD Cowen analysts lifted their price objectives for Nvidia stock from their previous targets on a split-adjusted basis.The split-adjusted stock price could make ownership more accessible to a wider range of investors, with Morgan Stanley analysts highlighting that Nvidia stock is more affordable than Advanced Micro De ...
Bank of America Just Raised Its Price Target on Nio Stock
Investor Place· 2024-06-10 19:40
What should Nio (NYSE:NIO) stock be priced at? Bank of America has a $6 price target on the Chinese electric vehicle (EV) company, which it raised from $5.90.The price target change came after Nio reported its first-quarter earnings on May 6, revealing a 7.2% year-over-year revenue decline to $1.37 billion. BofA analyst Ming Hsun Lee noted that the decline was attributed to a lower average sales price (ASP). He rationalized that Nio wants to get rid of its 2023 models in preparation for new models.Revenue i ...
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead Clinical Program at the 2024 SNMMI Annual Meeting
GlobeNewswire News Room· 2024-06-10 12:00
WILMETTE, Ill., June 10, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharmaceutical company focused on developing innovative treatments for cancer patients, is presenting today data from the preclinical development of its novel first-in-class lead radiopharma program MNPR-101-Zr at the 2024 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Toronto, Canada. SNMMI is the premier educational, scientific, and research event in the radiopharm ...
This Magnificent Dividend Stock Is Accelerating Its Growth by Adding $1 Billion to Its Acquisition Target
The Motley Fool· 2024-06-08 08:11
Realty Income is increasingly optimistic about its 2024 growth outlook.Realty Income (O -1.73%) is a terrific dividend stock. The real estate investment trust (REIT) has increased its dividend for 107 consecutive quarters. Its monthly payout currently yields nearly 6%, which is several times above the S&P 500's 1.3% dividend yield. The REIT's magnificent dividend should continue its steady rise. One factor driving that view is its growing optimism for securing new investments this year. The REIT recently ad ...
Fremont Provides Update on Urasar Exploration Program in Armenia: Seven Key Target Areas Identified
Newsfile· 2024-06-06 11:30
Fremont Provides Update on Urasar Exploration Program in Armenia: Seven Key Target Areas IdentifiedJune 06, 2024 7:30 AM EDT | Source: Fremont Gold Ltd.Vancouver, British Columbia--(Newsfile Corp. - June 6, 2024) - Fremont Gold Ltd. (TSXV: FRE) (FSE: FR20) (OTCQB: FRERF) ("Fremont" or the "Company") is pleased to provide an update on the 2024 exploration program at the Company's 100% owned Urasar Project ("Urasar" or the "Project") in northern Armenia.Dennis Moore, President and CEO of Fremont ...
Olink® Target 48 Immune Surveillance Panel – The Next Frontier in Immune Biomarker Profiling with Absolute Confidence
GlobeNewswire News Room· 2024-06-06 06:00
UPPSALA, Sweden, June 06, 2024 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research. More Confidence, More Insights, Less Sample Biomarker selection for Olink Target 48 Immune Surveillance were designed to give researchers the most effective platform for detec ...